Safety and efficacy of azacitidine in myelodysplastic syndromes

PURPOSE: The clinical efficacy, different dosages, treatment schedules, and safety of azacitidine are reviewed. SUMMARY: Azacitidine is the first drug FDA-approved for the treatment of myelodysplastic syndromes that has demonstrated improvements in overall survival and delaying time to progression t...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Vigil, Carlos E, Martin-Santos, Taida, Garcia-Manero, Guillermo
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2010
विषय:
Review
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948932/
https://ncbi.nlm.nih.gov/pubmed/20957213
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन